The present disclosure relates to the field of organic light-emitting materials, and more particularly, to a thermally activated delayed fluorescence material having red, green, or blue color, a synthesis method thereof, and application thereof. The thermally activated delayed fluorescence material having red, green, or blue color has the following structural formula: the present disclosure provides a novel thermally activated delayed fluorescence material having red, green, or blue color which has a lower singlet triplet energy level difference, a high RISC rate constant (kRISC), and a high photoluminescence quantum yield (PLQY). It has significant characteristics of a thermally activated delayed fluorescence material and a long service life that can be used in an electroluminescent display and a light-emitting equipment structure which are mass produced.

The present disclosure relates to the field of organic light-emitting materials, and more particularly, to a thermally activated delayed fluorescence material having red, green, or blue color, a synthesis method thereof, and application thereof. The thermally activated delayed fluorescence material having red, green, or blue color has the following structural formula: the present disclosure provides a novel thermally activated delayed fluorescence material having red, green, or blue color which has a lower singlet triplet energy level difference, a high RISC rate constant (kRISC), and a high photoluminescence quantum yield (PLQY). It has significant characteristics of a thermally activated delayed fluorescence material and a long service life that can be used in an electroluminescent display and a light-emitting equipment structure which are mass produced.

The present disclosure relates to the field of organic light-emitting materials, and more particularly, to a thermally activated delayed fluorescence material having red, green, or blue color, a synthesis method thereof, and application thereof. The thermally activated delayed fluorescence material having red, green, or blue color has the following structural formula: the present disclosure provides a novel thermally activated delayed fluorescence material having red, green, or blue color which has a lower singlet triplet energy level difference, a high RISC rate constant (kRISC), and a high photoluminescence quantum yield (PLQY). It has significant characteristics of a thermally activated delayed fluorescence material and a long service life that can be used in an electroluminescent display and a light-emitting equipment structure which are mass produced.

This invention relates to certain compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer. In another aspect, the disclosure relates to a pharmaceutical composition comprising a compound of Formula (1), Formula (1a), or Formula (1b), or a pharmaceutically acceptable salt thereof, and at least one of a pharmaceutically acceptable carrier, diluent or excipient.

This invention relates to certain compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer. In another aspect, the disclosure relates to a pharmaceutical composition comprising a compound of Formula (1), Formula (1a), or Formula (1b), or a pharmaceutically acceptable salt thereof, and at least one of a pharmaceutically acceptable carrier, diluent or excipient.

The invention provides compounds and methods of treating autophagy mediated diseases and disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits.

The invention relates to purely organic emitter molecules of a new type according to formula I and to the use thereof in optoelectronic devices, in particular in organic light-emitting diodes (OLEDs), comprising donor D: an aromatic or heteraromatic chemical group on which the HOMO is located and which optionally has at least one substitution; acceptor A: an aromatic or heteromatic chemical group on which the LUMO is located and which optionally has at least one substitution; bridge B1, bridge B2: organic groups that link the donor D and the acceptor A in a non-conjugated manner; wherein in particular the energy difference ΔE(S.sub.1−T.sub.1) between the lowest excited singlet (S1) state of the organic emitter molecule and the triplet (T1) state of the organic emitter molecule lying thereunder is less than 2000 cm.sup.−1.

The invention relates to purely organic emitter molecules of a new type according to formula I and to the use thereof in optoelectronic devices, in particular in organic light-emitting diodes (OLEDs), comprising donor D: an aromatic or heteraromatic chemical group on which the HOMO is located and which optionally has at least one substitution; acceptor A: an aromatic or heteromatic chemical group on which the LUMO is located and which optionally has at least one substitution; bridge B1, bridge B2: organic groups that link the donor D and the acceptor A in a non-conjugated manner; wherein in particular the energy difference ΔE(S.sub.1−T.sub.1) between the lowest excited singlet (S1) state of the organic emitter molecule and the triplet (T1) state of the organic emitter molecule lying thereunder is less than 2000 cm.sup.−1.

The present invention relates to novel small molecules of Formulas I, II, III, Ilia, Illb, and IV and pharmaceutically acceptable salts thereof, as well as the preparation and the use thereof.

The present invention relates to novel small molecules of Formulas I, II, III, Ilia, Illb, and IV and pharmaceutically acceptable salts thereof, as well as the preparation and the use thereof.